|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 38/17 | |||
| A61K 39/395 | |||
| A61K 39/00 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3057990 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14792686.9 |
| Europos patento paraiškos padavimo data | 2014-10-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-08-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/061071 |
| Data | 2014-10-17 |
| (87) | Numeris | WO 2015/058048 |
| Data | 2015-04-23 |
| (30) | Numeris | Data | Šalis |
| 201361892601 P | 2013-10-18 | US | |
| 201361901596 P | 2013-11-08 | US | |
| 201461952923 P | 2014-03-14 | US | |
| 201462055734 P | 2014-09-26 | US |
| (72) |
IOFFE, Ella, US
LOWY, Israel, US
THURSTON, Gavin, US
BUROVA, Elena, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | COMPOSITIONS COMPRISING A COMBINATION OF A VEGF ANTAGONIST AND AN ANTI-CTLA-4 ANTIBODY |
| COMPOSITIONS COMPRISING A COMBINATION OF A VEGF ANTAGONIST AND AN ANTI-CTLA-4 ANTIBODY |